Click on a filter below to refine your search. Remove a filter to broaden your search.
The findings were for veterans with chronic obstructive pulmonary disease, heart failure or interstitial lung disease.
Significant improvement also was seen in lung function, quality of life and severity of COPD symptoms.
Each 1 degree Celsius increase in temperature correlated with a 2% increase in odds of COPD exacerbation.
At 30 days after discharge, the mortality rate was 3.2% and skilled nursing facility use rate was 2.6%.
An increase was seen in prebronchodilator forced expiratory volume in one second with dupilumab versus placebo at weeks 12 and 52.
Wixela Inhub and Advair Diskus fluticasone-salmeterol are similarly effective and safe for chronic obstructive pulmonary disease.
Active treatment lowered SBP, improved 6-minute walk test and improved measures of endothelial function.
No reduction was seen in the number of self-reported exacerbations treated with oral corticosteroids, antibiotics or both.
One week of extended-release morphine does not significantly reduce the intensity of the worst breathlessness.
Just under three-quarters of patients with chronic kidney disease receive flu vaccines